SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenith Health Care informs about outcome of AGM

26 Aug 2024 Evaluate
Pursuant to regulation 30 (6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zenith Health Care has informed that members of Zenith Healthcare in their duly called and convened 30th Annual General Meeting held on Monday, the 26th August, 2024 at 10.30 AM (IST) through Video Conferencing (VC) where in following business were transacted. The meeting was commenced at 10.30 am and was concluded at 10.38 am. Ordinary Buisnesses: To receive, consider, approve and adopt the Audited Balance Sheet as at 31st March, 2024, and the Statement of Profit and together with Cash Flow Statement and Notes forming part thereto (Financial Statement) for the year ended on 31st March, 2024 and Report of the Board of Directors and Auditors thereon; To appoint a Director in place of Neela M. Raycha (DIN: 01258479), who retires by rotation and being eligible offers herself for re-appointment; etc. They are also enclosing summary of proceedings of the AGM of the Company, as required under Regulation 30, Part A of Schedule Ill to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations). Further, pursuant to Regulation 44(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 consolidated scrutinizer’s report along with voting results will be submitted on or before 28th September, 2024 and also be uploaded on the website of the Company.

The above information is a part of company’s filings submitted to BSE.

Zenith Health Care Share Price

3.27 0.03 (0.93%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.75
Dr. Reddys Lab 1270.95
Cipla 1333.55
Zydus Lifesciences 911.85
Lupin 2343.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×